A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

BACKGROUND: Platinum-based combinations are the standard second-line treatment for platinum-sensitive ovarian cancer (OC). This randomized phase II study was undertaken in order to compare the combination of carboplatin and pegylated liposomal doxorubicin (LD) with carboplatin and paclitaxel (CP) in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Bafaloukos, Dimitrios, Linardou, Helena, Aravantinos, Gerasimos, Papadimitriou, Christos, Bamias, Aristotelis, Fountzilas, George, Kalofonos, Haralabos P, Kosmidis, Paris, Timotheadou, Eleni, Makatsoris, Thomas, Samantas, Epaminondas, Briasoulis, Evangelos, Christodoulou, Christos, Papakostas, Pavlos, Pectasides, Dimitrios, Dimopoulos, Athanasios M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2010
Aiheet:
Research article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2823653/
https://ncbi.nlm.nih.gov/pubmed/20055981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-8-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia